Saturday, 17 October 2026European Markets

ITERA Stock Is 20% Up In The Last 10 Sessions

Loading stream...

(VIANEWS) - Shares of ITERA (Oslo Børs Benchmark Index_GI: ITERA.OL) jumped by a staggering 20.38% in 10 sessions from kr13.25 to kr15.95 at 20:37 EST on Monday, after five successive sessions in a row of gains. Oslo Børs Benchmark Index_GI is rising 0.29% to kr1,216.65, following the last session's upward trend.

ITERA's last close was kr15.65, 5.15% below its 52-week high of kr16.50.

About ITERA

Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.84.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 18.99. Meaning, the purchaser of the share is investing kr18.99 for every norwegian krone of annual earnings.

Moving Average

ITERA's value is way above its 50-day moving average of kr13.20 and way above its 200-day moving average of kr13.06.

More news about ITERA (ITERA.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com